Guangdong Hongjing Optoelectronic Technology Inc.
301479
Longkou Union Chemical
301209
Zhejiang Realsun Chemical
301212
4
NEW JCM GROUP
300157
5
Shenzhen S-king Intelligent Equipment
688328
US Stock MarketDetailed Quotes
TMO Thermo Fisher Scientific
- 421.340
- -2.900-0.68%
Close Apr 28 16:00 ET
- 421.340
- 0.0000.00%
Post 19:03 ET
159.05BMarket Cap24.71P/E (TTM)
432.850High416.840Low2.53MVolume429.930Open424.240Pre Close1.07BTurnover0.67%Turnover Ratio25.49P/E (Static)377.49MShares626.48552wk High3.22P/B158.72BFloat Cap409.85152wk Low1.60Dividend TTM376.71MShs Float666.688Historical High0.38%Div YieldTTM3.77%Amplitude11.870Historical Low421.979Avg Price1Lot Size
Thermo Fisher Scientific Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 29, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 29, 2024 | (Q1)Mar 30, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jul 1, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.18%10.36B | 0.05%42.88B | 4.68%11.4B | 0.23%10.6B | -1.37%10.54B | -3.41%10.35B | -4.58%42.86B | -4.93%10.89B | -0.96%10.57B | 10.69B |
| Operating revenue | 0.18%10.36B | 0.05%42.88B | 4.68%11.4B | 0.23%10.6B | -1.37%10.54B | -3.41%10.35B | -4.58%42.86B | -4.93%10.89B | -0.96%10.57B | --10.69B |
| Cost of revenue | -1.37%6.06B | -2.25%25.18B | 1.23%6.57B | 0.19%6.27B | -3.76%6.19B | -6.54%6.14B | -0.72%25.76B | -5.13%6.49B | -1.84%6.26B | 6.44B |
| Gross profit | 2.45%4.31B | 3.52%17.7B | 9.77%4.82B | 0.28%4.33B | 2.26%4.35B | 1.57%4.21B | -9.86%17.1B | -4.62%4.39B | 0.33%4.32B | 4.25B |
| Operating expense | -0.88%2.49B | 2.08%9.99B | 4.80%2.58B | 3.21%2.44B | -1.61%2.45B | 1.99%2.51B | -6.52%9.78B | -8.59%2.46B | -7.46%2.37B | 2.49B |
| Selling and administrative expenses | -21.16%1.72B | 1.78%8.6B | 3.33%2.2B | 2.39%2.1B | -1.59%2.11B | 3.02%2.18B | -6.09%8.45B | -7.26%2.13B | -7.20%2.05B | --2.15B |
| Research and development costs | 3.32%342M | 3.96%1.39B | 14.37%374M | 8.46%346M | -1.74%339M | -4.34%331M | -9.11%1.34B | -16.37%327M | -9.12%319M | --345M |
| Depreciation amortization depletion | --429M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Depreciation and amortization | --429M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit | 7.39%1.82B | 5.45%7.72B | 16.08%2.25B | -3.29%1.88B | 7.72%1.9B | 0.96%1.69B | -13.98%7.32B | 0.94%1.93B | 11.76%1.95B | 1.76B |
| Net non-operating interest income expense | -19.05%-100M | 37.10%-312M | -11.11%-90M | 30.09%-79M | 60.14%-59M | 45.45%-84M | -9.25%-496M | 31.93%-81M | -7.62%-113M | -148M |
| Non-operating interest income | -27.24%203M | 22.64%1.08B | -26.54%227M | 12.60%277M | 65.73%295M | 91.10%279M | 223.16%879M | 106.00%309M | 261.76%246M | --178M |
| Non-operating interest expense | -16.53%303M | 1.09%1.39B | -18.72%317M | -0.84%356M | 8.59%354M | 21.00%363M | 89.39%1.38B | 44.98%390M | 107.51%359M | --326M |
| Other net income (expense) | -400.00%-95M | 29.96%-367M | -89.38%-214M | 12.86%-61M | 60.66%-72M | 87.97%-19M | -140.37%-524M | -465.00%-113M | -89.19%-70M | -183M |
| Gain on sale of security | ---- | 145.65%21M | ---- | ---- | ---- | ---- | 71.43%-46M | ---- | ---- | ---- |
| Special income (charges) | -237.93%-98M | 17.43%-379M | -185.00%-228M | 46.43%-45M | 57.92%-77M | 74.11%-29M | -302.63%-459M | -45.45%-80M | -154.55%-84M | ---183M |
| -Less：Restructuring and merger&acquisition | 237.93%98M | -17.43%379M | 185.00%228M | -46.43%45M | -57.92%77M | -74.11%29M | 302.63%459M | 45.45%80M | 154.55%84M | --183M |
| Other non- operating income (expenses) | -70.00%3M | 52.63%-9M | -153.85%-7M | -214.29%-16M | --5M | 121.74%10M | -133.33%-19M | -93.37%13M | 450.00%14M | ---- |
| Income before tax | 1.95%1.62B | 11.73%7.04B | 11.55%1.94B | -1.30%1.74B | 23.43%1.77B | 16.58%1.59B | -19.62%6.3B | -2.08%1.74B | 10.24%1.77B | 1.43B |
| Income tax | -66.19%95M | 131.34%657M | 12.78%150M | 86.79%99M | 146.15%128M | 510.87%281M | -59.60%284M | -23.12%133M | 70.97%53M | 52M |
| Earnings from equity interest net of tax | -160.87%-14M | 28.81%-42M | 3,400.00%33M | 17.65%-14M | -425.00%-84M | 192.00%23M | 65.70%-59M | 96.67%-1M | 76.39%-17M | ---16M |
| Net income | 13.52%1.51B | 6.43%6.34B | 13.57%1.82B | -3.89%1.63B | 14.02%1.55B | 3.02%1.33B | -14.44%5.96B | 2.03%1.61B | 13.15%1.7B | 1.36B |
| Net income continuous Operations | 13.52%1.51B | 6.43%6.34B | 13.57%1.82B | -3.89%1.63B | 14.02%1.55B | 3.02%1.33B | -14.44%5.96B | 2.03%1.61B | 13.15%1.7B | --1.36B |
| Minority interest income | 0.00%4M | 107.50%3M | 75.00%-6M | 0 | 500.00%6M | 33.33%4M | -500.00%-40M | -1,100.00%-24M | -766.67%-20M | 1M |
| Net income attributable to the parent company | 13.48%1.51B | 5.67%6.34B | 12.27%1.83B | -4.96%1.63B | 13.74%1.55B | 3.03%1.33B | -13.74%6B | 3.43%1.63B | 14.72%1.72B | 1.36B |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 13.48%1.51B | 5.67%6.34B | 12.27%1.83B | -4.96%1.63B | 13.74%1.55B | 3.03%1.33B | -13.74%6B | 3.43%1.63B | 14.72%1.72B | 1.36B |
| Basic earnings per share | 14.99%3.99 | 6.83%16.58 | 13.51%4.79 | -4.05%4.26 | 14.73%4.05 | 3.89%3.47 | -12.56%15.52 | 4.71%4.22 | 16.23%4.44 | 3.53 |
| Diluted earnings per share | 15.03%3.98 | 6.99%16.53 | 13.81%4.78 | -3.85%4.25 | 15.10%4.04 | 4.22%3.46 | -12.37%15.45 | 4.74%4.2 | 16.62%4.42 | 3.51 |
| Dividend per share | 10.26%0.43 | 11.43%1.56 | 11.43%0.39 | 11.43%0.39 | 11.43%0.39 | 11.43%0.39 | 16.67%1.4 | 16.67%0.35 | 16.67%0.35 | 0.35 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |
Market Insights
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025